Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses-Reference-Cited by-同舟云学术

Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses

Published:2016-04-13 Issue:334 Volume:8 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Welters Marij J.¹,van der Sluis Tetje C.²,van Meir Hélène³⁴,Loof Nikki M.¹,van Ham Vanessa J.¹,van Duikeren Suzanne²,Santegoets Saskia J.¹,Arens Ramon²,de Kam Marieke L.⁴,Cohen Adam F.⁴,van Poelgeest Mariette I.³,Kenter Gemma G.⁵,Kroep Judith R.¹,Burggraaf Jacobus⁴,Melief Cornelis J.²⁶,van der Burg Sjoerd H.¹

Affiliation:

1. Department of Clinical Oncology, Leiden University Medical Center, 2300 RC Leiden, Netherlands.

2. Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2300 RC Leiden, Netherlands.

3. Department of Gynecology, Leiden University Medical Center, 2300 RC Leiden, Netherlands.

4. Centre for Human Drug Research, 2333 CL Leiden, Netherlands.

5. Department of Gynecology, Academic Medical Center, 1100 DD Amsterdam, Netherlands.

6. ISA Pharmaceuticals, 2333 CH Leiden, Netherlands.

Abstract

Therapeutic vaccination against HPV16 is effective with chemotherapy for advanced cervical cancer patients.

Funder

Dutch Cancer Society

Centre for Human Drug Research

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference35 articles.

1. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia

2. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma;Burke T. W.;Obstet. Gynecol.,1987

3. Recurrent cervical carcinoma after radical hysterectomy

4. Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study

5. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A recent perspective on designing tumor vaccines for tumor immunology;International Immunopharmacology;2024-12

2. Old concepts, new tricks: How peptide vaccines are reshaping cancer immunotherapy?;International Journal of Biological Macromolecules;2024-09

3. Enhancement of HPV therapeutic peptide-based vaccine efficacy through combination therapies and improved delivery strategies: A review;Human Vaccines & Immunotherapeutics;2024-08-28

4. Intraepithelial CD15 infiltration identifies high-grade anal dysplasia in people with HIV;JCI Insight;2024-06-20

5. Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity;Cancer Immunology Research;2024-04-17